Research ArticleClinical Studies

First-line Chemotherapy with Fluorouracil-Epirubicin-Navelbine (FEN) Combination in Advanced Breast Cancer

A. ARDAVANIS, D. TRYFONOPOULOS, G. ORPHANOS, G. IOANNIDIS, M. KARAMOUZIS and G. RIGATOS
Anticancer Research November 2005, 25 (6C) 4493-4498;

Article Information

vol. 25 no. 6C 4493-4498
PubMed 
16334132
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 25, 2005
  • Accepted July 22, 2005
  • Published online November 1, 2005.
Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. A. ARDAVANIS,
  2. D. TRYFONOPOULOS,
  3. G. ORPHANOS,
  4. G. IOANNIDIS,
  5. M. KARAMOUZIS and
  6. G. RIGATOS
  1. First Department of Medical Oncology, St. Savas Anticancer Hospital, Athens, Greece
  1. Correspondence to: Dr A. Ardavanis, 1st Department of Medical Oncology, St. Savas Anticancer Hospital, 171 Alexandras Avenue, 115 22 Athens, Greece. Tel: 6944421525, e-mail: ardavanis{at}yahoo.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
First-line Chemotherapy with Fluorouracil-Epirubicin-Navelbine (FEN) Combination in Advanced Breast Cancer
A. ARDAVANIS, D. TRYFONOPOULOS, G. ORPHANOS, G. IOANNIDIS, M. KARAMOUZIS, G. RIGATOS
Anticancer Research Nov 2005, 25 (6C) 4493-4498;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section